Product Information
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1256 per EA under NDC 00378204501. Its NADAC has been published 656 times since Nov 28, 2013.
FDA first approved this application on Sep 17, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378204501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090596FDA Approved
9/17/2010
TE Code
AB
On Market Since
9/17/2010
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has been published 656 times since Nov 28, 2013, and over the history we have for it it has declined 86.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1256 per EA |
|---|---|
| All-time high | $1.0399 (Feb 12, 2014) |
| All-time low | $0.1091 (Nov 20, 2024) |
| 52-week high | $0.1744 |
| 52-week low | $0.1256 |
| Median price | $0.2319 |
| Average price | $0.3261 |
| Largest weekly change | +64.8% (Sep 23, 2020) |
| Weeks tracked | 656 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Mylan Pharmaceuticals Inc., is $0.1256 per EA (NDC 00378204501), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has declined 86.2%. It has been tracked across 656 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1091 (Nov 20, 2024) to a high of $1.0399 (Feb 12, 2014), with a median of $0.2319 per EA.
Are there cheaper alternatives to TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 00378204501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.